Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Molecular and Clinical Oncology|August 8, 2017
Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinomaHeike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.Oncoimmunology|May 10, 2019
The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.BMC Cancer|January 8, 2020
Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinomaSimon Schallenberg, Julian Bork, Ahlem Essakly, et al.Journal of Cancer Research and Clinical Oncology|June 28, 2020
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinomaFlorian Gebauer, Max Krämer, Christiane Bruns, et al.Cancers|July 8, 2020
Y Chromosome Loss is a Frequent Event in Barrett's Adenocarcinoma and Associated with Poor OutcomeHeike Loeser, Christina B Wölwer, Hakan Alakus, et al.Translational Oncology|December 23, 2019
PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and PrognosisAhlem Essakly, Heike Loeser, Max Kraemer, et al.The American Journal of Pathology|March 21, 2012
MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samplesMelanie von Brandenstein, Jency J Pandarakalam, Lukas Kroon, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 6, 2021
Optimized PD-L1 scoring of gastric cancerBirgid Schoemig-Markiefka, Jana Eschbach, Andreas H Scheel, et al.Journal of Cancer Research and Clinical Oncology|July 6, 2018
Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagusPatrick Sven Plum, Dita Ulase, Elfriede Bollschweiler, et al.The American Journal of Surgical Pathology|September 25, 2013
Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testingHelen Künstlinger, Sebastian Huss, Sabine Merkelbach-Bruse, et al.Pageof 3